Giá của BioAge Labs Inc. là bao nhiêu (BIOA)

Giá của BioAge Labs Inc. (BIOA) là $9.50

Mũ thị trường của BioAge Labs Inc. là gì (BIOA)

Giới hạn thị trường của BioAge Labs Inc. (BIOA) là $357.67M

Lịch sử giá BioAge Labs Inc. (BIOA)

BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.

Năm	Hiệu suất
2026 (TTM)	19.87%
2025	48.86%
2024	0.00%

Năm

Hiệu suất

2026 (TTM)

19.87%

2025

48.86%

2024

0.00%

Công ty	Giá cổ phiếu	Thay đổi 1năm%	Quốc gia
Vertex Pharmaceuticals Incorporated VRTX.US	$548.98	40.40%	US
Argenx SE ARGX.US	$1.03K	44.32%	NL
CSL Limited CSL.AX	$121.37	-11.93%	AU
Moderna, Inc. MRNA.US	$144.39	499.38%	US
Lonza Group AG LONN.SW	$748.60	4.92%	CH

Công ty

Giá cổ phiếu

Thay đổi 1năm%

Quốc gia